St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Explore comprehensive information about childhood and adolescent cancer.
Find information about types of blood disorders in children and adolescents.
Learn more about infectious diseases in children and adolescents.
Treatments, Tests, and Procedures
Learn about treatments, tests, procedures, medicines, and side effects.
Learn about navigating and managing medical care for children and adolescents.
Emotional Support and Daily Life
Learn about emotional support and resources to help with day-to-day living.
Learn more through videos, blogs, stories, and other resources.
Some female childhood cancer survivors may have problems with their reproductive health — menstrual periods, pregnancy, and childbearing — because of certain treatments they received.
The effect, if any, depends on the:
Treatments are available for many conditions that affect the reproductive system.
It is important to understand how the female reproductive system functions and how it may be affected by cancer treatment.
The organs of the female reproductive system work together so a woman can:
Females have two ovaries. During puberty, the pituitary gland in the brain signals the ovaries to start making more estrogen and progesterone. These are hormones necessary for the reproductive system to work.
Once a month, the ovaries typically release at least 1 egg. If the egg is fertilized by sperm, the female becomes pregnant. If it is not fertilized, the woman will have her menstrual period. This cycle repeats about every 28 days. With each menstrual cycle, the supply of eggs decreases.
A girl is born with all the eggs she will ever have. When her supply becomes low, a woman begins menopause. When menstrual periods stop, a woman usually cannot get pregnant anymore. Menopause can occur in a woman’s 40s or 50s. The average age is 51. Menopause is considered early if it happens before the age of 40.
Alkylating Drugs |
Heavy Metal Drugs |
---|---|
|
|
Non-classical alkylators |
|
|
Radiation therapy that affects a patient’s pelvic area, reproductive organs, and pituitary gland in the brain may affect a patient’s fertility. The treatment may decrease the number of eggs or affect the quality of the eggs.
Radiation directly to or near the ovaries can cause them to stop working. Radiation therapy to the abdomen, pelvis, and lower spine can affect the uterus and increase the risk of miscarriage, premature labor, low birth weight, and problems during labor.
Brain radiation can damage the pituitary gland in the brain. The pituitary gland produces two hormones needed for the ovaries to function correctly – FSH (follicle-stimulating hormone) and LH (luteinizing hormone.) FSH stimulates the ovarian follicles to produce eggs. LH signals the follicles to release eggs. High levels of radiation to this area of the brain can lead to low levels of these hormones.
The combination of pelvic radiation and high doses of alkylating agents causes the highest risk of damage to reproductive function.
Tumors and/or surgery that result in damage to the pituitary gland can cause the ovaries to stop working due to deficiency in LH and FSH. This condition is called central hypogonadism.
Surgery that removes both ovaries before the normal age of menopause causes premature ovarian failure.
Removal of one ovary before the normal age of menopause may cause menopause to happen a few years earlier than normal.
In general, females who are adolescents and young adults at the time of treatment are at higher risk for problems than younger girls.
Damage to ovaries can cause puberty to be delayed (no signs of breast development after age 13 years) or to stall (no progress in signs of puberty, no onset of periods past the age of 16 years). Affected girls will need hormone treatment prescribed by a doctor to experience puberty and have a menstrual period.
Many females will temporarily stop having their period during treatment, but it may return later. That timing is unpredictable. It could take several years. It is important that women take birth control if they are sexually active and don’t want to become pregnant.
Cancer treatment can cause women to stop menstruating earlier than expected (before the age of 40.) Heath care professionals recommend that women at risk for early menopause not put off trying to have children beyond the early 30s if they are able.
Women with ovarian failure don’t produce enough estrogen, which is needed for healthy bones, a healthy heart, and overall well-being. Girls at risk for this problem may need to consult an endocrinologist and/or gynecologist.
Infertility is defined as not being able to get pregnant and have a biologic child after 1 year of unprotected sexual intercourse. Women at risk for infertility may want to see a fertility specialist.
Women who had radiation to the pelvis, lower spine or total body (TBI) may be at increased risk for miscarriage, premature delivery, low birthweight infants, or problems during labor. Survivors who received these treatments and who are planning to become pregnant or are already pregnant should ask to see an obstetrician/ gynecologist (OB/GYN) who specializes in high-risk pregnancies.
Women who had chemotherapy with anthracyclines could have heart problems during pregnancy and labor. Survivors are encouraged to talk to their OB/GYN about the possible need to have a heart muscle function evaluation.
Survivors should have annual physical examinations that include:
If the health care provider sees problems in these areas, he or she may refer the survivor to an endocrinologist or other specialists.
Treatments are available for many conditions that affect hormones and fertility.
For women with ovarian failure, a bone density test to check for thinning of the bones may also be recommended.
For more information, read the Children’s Oncology Group’s Female Health Issues after Cancer Treatment.
—
Together does not endorse any branded product mentioned in this article.
—
Reviewed: June 2020
Some childhood cancer treatments can affect a female’s ability to have children. Families should ask about the impact on fertility before therapy starts.
Some childhood cancers and treatments can affect the development and functioning of the endocrine system.
Childhood cancer therapy may sometimes affect male reproductive functions later in life. It is important that boys who are at risk for reproductive health problems have a yearly check-up for related concerns.